Ad is loading...
HSMFX
Price
$13.57
Change
-$0.05 (-0.37%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

HSMFX vs VISVX

Header iconHSMFX vs VISVX Comparison
Open Charts HSMFX vs VISVXBanner chart's image
Hartford Small Cap Value F
Price$13.57
Change-$0.05 (-0.37%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
HSMFX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HSMFX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSMFX is a StrongSell and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. HSMFX (133M). VISVX pays higher dividends than HSMFX: VISVX (1.90) vs HSMFX (1.69). HSMFX was incepted earlier than VISVX: HSMFX (8 years) vs VISVX (27 years). HSMFX is a more actively managed with annual turnover of: 52.00 vs. VISVX (16.00). VISVX has a lower initial minimum investment than HSMFX: VISVX (3000) vs HSMFX (1000000). HSMFX (29.52) and VISVX (28.71) have marching annual gain over last year. VISVX return over 5 years is better than : 57.32 vs. HSMFX (35.69).
HSMFXVISVXHSMFX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years27 years-
Gain YTD16.48115.433107%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets133M57.6B0%
Annual Yield % from dividends1.691.9089%
Returns for 1 year29.5228.71103%
Returns for 3 years0.0313.230%
Returns for 5 years35.6957.3262%
Returns for 10 yearsN/A108.21-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics